Number of items: 6.
2025
Cooke, S. F. et al.
(2025)
Targeting MDM2 homodimer and heterodimer disruption with DRx-098D in TP53 wild-type and mutant cancer cells.
Molecular Therapy Oncology, 33(3),
201029.
(doi: 10.1016/j.omton.2025.201029)
(PMID:40896364)
(PMCID:PMC12395054)
2024
Main, Alice, Mary, Sheon
ORCID: https://orcid.org/0000-0001-9392-3020, Sin, Yuan Yan
ORCID: https://orcid.org/0000-0001-6537-5266, Wright, Tom A., Ling, Jiayue, Blair, Connor M., Smith, Godfrey L.
ORCID: https://orcid.org/0000-0003-4821-9741, Fuller, Will
ORCID: https://orcid.org/0000-0002-5883-4433 and Baillie, George S.
ORCID: https://orcid.org/0000-0003-2469-6316
(2024)
SUMOylation of cardiac myosin binding protein-C reduces its phosphorylation and results in impaired relaxation following treatment with isoprenaline.
International Journal of Biochemistry and Cell Biology, 176,
106668.
(doi: 10.1016/j.biocel.2024.106668)
(PMID:39321569)
Thongyim, Saruda, Wright, Thomas A., Sattayawat, Pachara, Kaewkod, Thida, Baillie, George S.
ORCID: https://orcid.org/0000-0003-2469-6316, Tragoolpua, Yingmanee, Jangsutthivorawat, Siriphorn and Panya, Aussara
(2024)
Clinacanthus nutans extract lowers periodontal inflammation under high-glucose conditions via inhibiting NF-κB signaling pathway.
Frontiers in Pharmacology, 15,
1410419.
(doi: 10.3389/fphar.2024.1410419)
Sin, Y. Y. et al.
(2024)
Beta-amyloid interacts with and activates the longform phosphodiesterase PDE4D5 in neuronal cells to reduce cAMP availability.
FEBS Letters, 598(13),
pp. 1591-1604.
(doi: 10.1002/1873-3468.14902)
(PMID:38724485)
Cooke, S. F. et al.
(2024)
Disruption of the pro-oncogenic c-RAF–PDE8A complex represents a differentiated approach to treating KRAS–c-RAF dependent PDAC.
Scientific Reports, 14,
8998.
(doi: 10.1038/s41598-024-59451-3)
(PMID:38637546)
(PMCID:PMC11026450)
2023
Wright, Thomas A., Gemmell, Alistair O., Tejeda, Gonzalo S.
ORCID: https://orcid.org/0000-0002-2900-6276, Blair, Connor M. and Baillie, George S.
ORCID: https://orcid.org/0000-0003-2469-6316
(2023)
Cancer: phosphodiesterase type 4C (PDE4C), the forgotten subfamily as a therapeutic target.
International Journal of Biochemistry and Cell Biology, 162,
106453.
(doi: 10.1016/j.biocel.2023.106453)
(PMID:37499270)
This list was generated on Mon Mar 16 20:37:05 2026 GMT.